Study of Tomotherapy in Patients With Benign Brain Tumour

Status Completed

Clinical Trial Summary

Although malignant brain tumors are the most common type of primary brain tumor, there are a number of other benign brain tumors that exist. Many difficulties exist with treating these tumors that have led to controversies in the best treatment. A common issue among these brain tumors is the risk of long term side effects from treatment. What limits the use of curative radiation therapy is the ability to deliver a maximal dose to the tumor while minimizing the amount of radiation to the normal structures in the brain. A new method of delivering radiation, called tomotherapy, has been acquired at the Cross Cancer Institute (CCI) and will be used in this study. It has the ability to deliver a high dose of radiation to the tumor while minimizing the amount of radiation to normal brain structures. This study will use this method of radiation therapy to deliver radiation and see if the long term side effects from radiation therapy can be reduced.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Brain Neoplasms

Clinical Trial Details

NCT number	NCT00128986
Study type	Interventional
Source	AHS Cancer Control Alberta
Contact
Status	Completed
Phase	Phase 1
Start date	May 2005
Completion date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02810899` - Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy	Phase 4
Withdrawn	`NCT00977795` - A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors	Phase 1/Phase 2
Recruiting	`NCT00787982` - Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors	Phase 1/Phase 2
Withdrawn	`NCT00555984` - Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors	N/A
Completed	`NCT00038441` - Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas	Phase 1/Phase 2
Recruiting	`NCT03619694` - Role of MR Spectroscopy in Brain Tumors
Withdrawn	`NCT01236586` - RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia	Phase 1
Unknown status	`NCT02775136` - An Evaluation of a Non-invasive Brain Monitor	N/A
Completed	`NCT01244737` - FLT-PET Imaging of Brain Tumors in Children	Phase 2
Completed	`NCT00993057` - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia	Early Phase 1
Terminated	`NCT00769093` - Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy	Phase 1
Completed	`NCT00392119` - MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors	Phase 1
Terminated	`NCT00038389` - Study of Vioxx and Radiation Therapy for Brainstem Glioma	Phase 1
Completed	`NCT00062478` - Study of Karenitecin (BNP1350) in Patients With Brain Tumors	Phase 2
Recruiting	`NCT05049148` - Platelets Activation in Brain Neoplasms	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting	`NCT04712721` - Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.	Early Phase 1
Completed	`NCT02881957` - Hypovitaminosis D in Neurocritical Patients	Phase 2/Phase 3
Terminated	`NCT01954576` - NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme	N/A
Recruiting	`NCT05538130` - A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors	Phase 1